United Therapeutics Corporation ( UTHR) - Stock Earnings
UTHR Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
UTHR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 364.3 million USD | 790.2 million USD |
| 2026Q1 | 274.9 million USD | 781.5 million USD |
| 2026Q2 | 333.0 million USD | 783.3 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
UTHR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 984.8 million USD | 2.3 billion USD |
| 2024 | 1.2 billion USD | 2.9 billion USD |
| 2025 | 1.3 billion USD | 3.2 billion USD |
| 2026 Est. | — | — |
UTHR
Price: $549.16
Earnings Per Share: 27.93 USD
P/E Ratio: 18.46
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 115651
Ebitda: 331.7 millionMarket Capitalization: 22.9 billion